, Tracking Stock Market Picks
Enter Symbol:
Cubist Pharmaceuticals, Inc. (CBST) [hlAlert]

up 344.88 %

Cubist Pharmaceuticals, Inc. (CBST) rated Buy by Merriman Curhan Ford

Posted on: Thursday,  Oct 30, 2008  8:25 AM ET by Merriman Curhan Ford

Merriman Curhan Ford rated Buy Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) on 10/30/2008, when the stock price was $22.77.
Since then, Cubist Pharmaceuticals, Inc. has gained 344.88% as of 01/16/2015's recent price of $101.30.
If you would have followed this Merriman Curhan Ford's recommendation on CBST, you would have gained 344.88% of your investment in 2269 days.

Cubist Pharmaceuticals, Inc. is a biopharmaceutical company focused on the research, development and commercialization of pharmaceutical products that address unmet medical needs in the acute care environment. In the U.S., Cubist markets CUBICIN, the first antibiotic in a new class of antiinfectives called lipopeptides. The Cubist product pipeline includes our lipopeptide program and our natural products screening program. Cubist is headquartered in Lexington, MA.

We occupy a unique niche among our investment banking peers: we offer our clients both traditional sell-side equity research and primary market research, and we focus on high-potential sectors such as CleanTech, Consumer/Internet/Media, Health Care and Tech/Telecom. Our institutional and corporate clients get the best of both worlds: expertise from our analysts and access to experts through our Panel Intelligence platform.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/30/2008 8:25 AM Buy
as of 12/24/2008
1 Week down  -9.54 %
1 Month down  -0.12 %
3 Months down  -33.31 %
1 YTD down  -33.31 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy